Drug Profile
Glioblast-13
Alternative Names: GB-13Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Targepeutics
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Colorectal cancer; Glioma; Head and neck cancer; Malignant melanoma
Most Recent Events
- 29 Apr 2014 No development reported - Preclinical for Colorectal cancer in USA (unspecified route)
- 29 Apr 2014 No development reported - Preclinical for Glioma in USA (unspecified route)
- 29 Apr 2014 No development reported - Preclinical for Head and neck cancer in USA (unspecified route)